Cargando…
Evaluation of the effect of selective serotonin reuptake inhibitors on bone mineral density: an observational cross-sectional study
SUMMARY: Sixty patients diagnosed with generalized anxiety disorder and treated with either paroxetine, sertraline, or citalopram for at least 12 months were enrolled in this study, and the bone mineral density (BMD) of the patients was compared with that of 40 healthy volunteers. Selective serotoni...
Autores principales: | Ak, E., Bulut, S. D., Bulut, S., Akdağ, H. A., Öter, G. B., Kaya, H., Kaya, O. B., Şengül, C. B., Kısa, C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer London
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4286623/ https://www.ncbi.nlm.nih.gov/pubmed/25187118 http://dx.doi.org/10.1007/s00198-014-2859-2 |
Ejemplares similares
-
Are Selective Serotonin Reuptake Inhibitors a Secondary Cause of Low Bone Density?
por: Chau, Kim, et al.
Publicado: (2012) -
Sentiment Analysis of Online Reviews for Selective Serotonin Reuptake Inhibitors and Serotonin–Norepinephrine Reuptake Inhibitors
por: Compagner, Chad, et al.
Publicado: (2021) -
The Necessity of Bone Densitometry for Patients Taking Selective Serotonin Reuptake Inhibitors
por: An, Ki-Yong, et al.
Publicado: (2013) -
Clinical pharmacology of serotonin selective reuptake inhibitors /
por: Preskorn, Sheldon
Publicado: (1996) -
Selective serotonin reuptake inhibitors and Alzheimer’s disease
por: Mdawar, Bernadette, et al.
Publicado: (2019)